Simulect (Basiliximab)

10 mg/2.5mL · Injection Powder for Solution

By Novartis Pharmaceuticals Corporation

Basiliximab · Powder for Injection · 10 mg/2.5mL · IV

NDC: 00078-0393
Route: Intravenous
Therapeutic class: Interleukin 2 Receptor Antagonists [MoA], Interleukin 2 Receptor-directed Antibody Interactions [MoA], Interleukin-2 Receptor Blocking Antibody
Marketing category: BLA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a Quote

Request this medication.

Tell us the quantity you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs